【摘要】：戰(zhàn)略性新興生物醫(yī)藥業(yè)是新興科技與新興產(chǎn)業(yè)的深度融合，是否擁有共性關(guān)鍵技術(shù)決定著其發(fā)展的成功與否。隨著產(chǎn)業(yè)規(guī)模的擴(kuò)大和市場(chǎng)競(jìng)爭(zhēng)的加劇，產(chǎn)業(yè)共性技術(shù)作為服務(wù)項(xiàng)目從企業(yè)內(nèi)部分離出來，形成獨(dú)立的生產(chǎn)性服務(wù)業(yè)，并且全面地參與到生物醫(yī)藥產(chǎn)業(yè)發(fā)展的各個(gè)層面，成為新型技術(shù)和自主創(chuàng)新的主要提供者和傳播者。重視與支持產(chǎn)業(yè)共性技術(shù)的研發(fā)與應(yīng)用，是掌控生物醫(yī)藥產(chǎn)業(yè)未來發(fā)展方向的重要手段。本文旨在通過對(duì)產(chǎn)業(yè)共性技術(shù)產(chǎn)業(yè)化的研究，為生物醫(yī)藥業(yè)共性技術(shù)從而整個(gè)戰(zhàn)略性新興生物醫(yī)藥業(yè)提供發(fā)展的對(duì)策和建議。 論文的主要內(nèi)容包括幾個(gè)方面： 首先，分析了戰(zhàn)略性新興產(chǎn)業(yè)和產(chǎn)業(yè)共性技術(shù)發(fā)展的選題背景，闡述了選題的理論和現(xiàn)實(shí)意義，基于研究?jī)?nèi)容繪制研究框架圖。 其次，論文整理和歸納了產(chǎn)業(yè)共性技術(shù)以及共性技術(shù)產(chǎn)業(yè)化的相關(guān)理論，為繪制專利地圖和構(gòu)建模型提供理論鋪墊和理論基礎(chǔ)。 第三，沿著對(duì)技術(shù)預(yù)見、供給和擴(kuò)散的成長(zhǎng)路線，研究產(chǎn)業(yè)共性技術(shù)，構(gòu)建匯集技術(shù)預(yù)見、技術(shù)供給和技術(shù)擴(kuò)散三者為一體的共性技術(shù)產(chǎn)業(yè)鏈。 第四，在產(chǎn)業(yè)共性技術(shù)基礎(chǔ)上，形成完整統(tǒng)一且具有邏輯體系的產(chǎn)業(yè)鏈。一是在共性技術(shù)預(yù)見方面，引用專利地圖法繪制共性技術(shù)綜合路線圖；二是在共性技術(shù)供給方面，對(duì)比分析項(xiàng)目組織、技術(shù)聯(lián)盟、科研基地和共性技術(shù)研究機(jī)構(gòu)四種組織形式；三是在共性技術(shù)擴(kuò)散方面，根據(jù)供給組織形式探討相應(yīng)的擴(kuò)散組織形式。 第五，搜集生物醫(yī)藥產(chǎn)業(yè)共性技術(shù)的專利數(shù)據(jù)，，對(duì)生物醫(yī)藥業(yè)共性技術(shù)的產(chǎn)業(yè)化作用和影響進(jìn)行了實(shí)例分析。繪制生物醫(yī)藥產(chǎn)業(yè)共性技術(shù)綜合路線圖和研發(fā)擴(kuò)散組織形式綜合圖，搜集整理全國(guó)31個(gè)省市地區(qū)相關(guān)的指標(biāo)數(shù)據(jù)并采用DEA兩階段鏈?zhǔn)骄W(wǎng)絡(luò)模型評(píng)價(jià)了生物醫(yī)藥業(yè)共性技術(shù)產(chǎn)業(yè)鏈的投入產(chǎn)出效率。根據(jù)研究結(jié)果提出發(fā)展戰(zhàn)略性新興生物醫(yī)藥業(yè)共性技術(shù)的有關(guān)建議。 論文所構(gòu)建的完整統(tǒng)一的產(chǎn)業(yè)鏈，為生物醫(yī)藥業(yè)共性技術(shù)的產(chǎn)業(yè)化，提供了理論依據(jù)以及實(shí)踐操作方法，對(duì)共性技術(shù)產(chǎn)業(yè)化的理論與實(shí)踐進(jìn)行了新的探索。
[Abstract]:The strategic emerging biomedical industry is the deep integration of the emerging technology and the emerging industry, and whether it has the common key technology determines the success of its development or not. With the expansion of industrial scale and the intensification of market competition, industry common technology is separated from the enterprise as a service item to form independent producer services, and participate in all aspects of the development of bio-pharmaceutical industry in an all-round way. Become the main provider and communicator of new technology and independent innovation. It is an important means to control the future development direction of biopharmaceutical industry by attaching importance to and supporting the research and development and application of common technology in biopharmaceutical industry. The purpose of this paper is to provide countermeasures and suggestions for the development of the whole strategic emerging biomedical industry through the study of industrialization of industrial commonness technology for biomedicine industry. The main contents of this paper include several aspects: firstly, this paper analyzes the background of the topic selection of strategic emerging industries and the development of common technology of industry, expounds the theoretical and practical significance of the topic selection, and draws the research framework diagram based on the research content. Secondly, the thesis summarizes the related theories of industry common technology and industrialization of common technology, which provides the theoretical foundation for drawing patent map and constructing model. Thirdly, along the growth route of technology foresight, supply and diffusion, we study the common technology of industry, and construct a common technology industry chain which integrates technology foresight, technology supply and technology diffusion. Fourth, on the basis of industry common technology, form a complete unified and logical system of industrial chain. In the aspect of common technology foresight, the patent map method is used to draw the comprehensive road map of common technology, and in the aspect of common technology supply, four kinds of organization forms are compared and analyzed: project organization, technology alliance, scientific research base and common technology research institution; Third, in the aspect of diffusion of common technology, the corresponding forms of diffusion organization are discussed according to the form of supply organization. Fifthly, the patent data of common technology in bio-medicine industry are collected, and the industrialization effect and influence of common technology in bio-medicine industry are analyzed. To draw a comprehensive road map of common technologies in the biomedical industry and a comprehensive map of the organizational forms of R & D and diffusion, The input-output efficiency of common technology industry chain in biomedical industry was evaluated by using DEA two-stage chain network model and collected and sorted out from 31 provinces, cities and regions in China. According to the research results, some suggestions for the development of common technologies in strategic biomedical industry are put forward. The integrated and unified industrial chain constructed in this paper provides the theoretical basis and practical operation method for the industrialization of common technology in biomedical industry, and makes a new exploration on the theory and practice of industrialization of common technology.
【學(xué)位授予單位】：長(zhǎng)沙理工大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2013
【分類號(hào)】：F426.72

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 任麗;沙凱;;我國(guó)共性技術(shù)篩選標(biāo)準(zhǔn)研究[J];北京機(jī)械工業(yè)學(xué)院學(xué)報(bào);2006年03期

2 謝元昊;王一濤;譚睿;;生物醫(yī)藥領(lǐng)域的技術(shù)預(yù)見[J];成都中醫(yī)藥大學(xué)學(xué)報(bào);2008年04期

3 張春勛;;我國(guó)汽車零部件產(chǎn)業(yè)技術(shù)創(chuàng)新能力提升路徑[J];重慶工商大學(xué)學(xué)報(bào)(西部論壇);2007年03期

4 陳文俊;賀正楚;吳艷;;基于R&D指標(biāo)的先導(dǎo)性戰(zhàn)略新興產(chǎn)業(yè)發(fā)現(xiàn)研究[J];財(cái)經(jīng)理論與實(shí)踐;2013年01期

5 賀正楚;吳艷;張蜜;文先明;;我國(guó)生產(chǎn)服務(wù)業(yè)與戰(zhàn)略性新興產(chǎn)業(yè)融合問題研究[J];管理世界;2012年12期

6 侯學(xué)鋼;上海城市功能轉(zhuǎn)變和生產(chǎn)服務(wù)業(yè)的軟化[J];上海經(jīng)濟(jì)研究;1998年08期

7 胡小江;政府參與共性技術(shù)研發(fā)必要性的理論分析[J];今日科技;2004年11期

8 周紅英;賀正楚;張訓(xùn);;戰(zhàn)略性新興產(chǎn)業(yè)與我國(guó)產(chǎn)業(yè)結(jié)構(gòu)優(yōu)化升級(jí)[J];經(jīng)濟(jì)地理;2011年12期

9 張良橋;賀正楚;吳艷;;基于灰色關(guān)聯(lián)分析的戰(zhàn)略性新興產(chǎn)業(yè)評(píng)價(jià)——以生物醫(yī)藥為例[J];經(jīng)濟(jì)數(shù)學(xué);2010年03期

10 李紀(jì)珍;產(chǎn)業(yè)共性技術(shù)發(fā)展的政府作用研究[J];技術(shù)經(jīng)濟(jì);2005年09期

相關(guān)博士學(xué)位論文 前5條

1 鄭才林;生產(chǎn)性服務(wù)對(duì)不同階段產(chǎn)業(yè)集群競(jìng)爭(zhēng)力影響研究[D];浙江大學(xué);2008年

2 鄒樵;共性技術(shù)擴(kuò)散機(jī)理與政府行為研究[D];華中科技大學(xué);2008年

3 張穎;湖北大重型數(shù)控機(jī)床產(chǎn)業(yè)技術(shù)路線圖研究[D];華中科技大學(xué);2010年

4 楊勇;重慶生物醫(yī)藥產(chǎn)業(yè)技術(shù)預(yù)見及其對(duì)策研究[D];第三軍醫(yī)大學(xué);2009年

5 石忠國(guó);生物技術(shù)產(chǎn)業(yè)區(qū)域競(jìng)爭(zhēng)力評(píng)價(jià)與培育策略[D];電子科技大學(xué);2012年

本文編號(hào)：2432068